Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology

Dose-response with stereotactic body radiotherapy for #ProstateCancer: a multi-institutional analysis of PSA kinetics and biochemical control

Dose-response with stereotactic body radiotherapy for #ProstateCancer: a multi-institutional analysis of PSA kinetics and biochemical control 



https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/126262-dose-response-with-stereotactic-body-radiotherapy-for-prostate-cancer-a-multi-institutional-analysis-of-prostate-specific-antigen-kinetics-and-biochemical-control-beyond-the-abstract.html?pk_campaign=Levin-Epstein_SocialBTA_126262&fbclid=IwAR0lWcjzfAK7K3C6GAyqiCqs6jckErW2T5IcpCvJarHIBjDJ40-GPkVe6QM

Read more

Optimal radiologic assessment after systemic therapy for muscle-invasive #BladderCancer. Presentation by Valeria Panebianco, MD Sapienza Università di Roma. #GU21 written coverage by Christopher Wallis, MD, PhD Vanderbilt Health on UroToday

Optimal radiologic assessment after systemic therapy for muscle-invasive #BladderCancer. Presentation by Valeria Panebianco, MD Sapienza Università di Roma. #GU21 written coverage by Christopher Wallis, MD, PhD Vanderbilt Health on UroToday 



https://www.urotoday.com/conference-highlights/asco-gu-2021/bladder-cancer/128095-asco-gu-2021-optimal-radiologic-assessment-after-systemic-therapy-for-muscle-invasive-bladder-cancer.html?pk_campaign=Panebianco_SocialASCOGU21_ID128095&fbclid=IwAR36qGCgE7CMb5Sv_yUGhwOQ6OFxbowfSBD_IPSzengF8rFH3-NQsH_iz3w

Read more

Low-intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic #ErectileDysfunction who are PDE5i non-responders: a multicenter single-arm #ClinicalTrial.

Low-intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic #ErectileDysfunction who are PDE5i non-responders: a multicenter single-arm #ClinicalTrial. #BeyondTheAbstract with Tommaso Cai and Alessandro Palmieri on UroToday


https://www.urotoday.com/recent-abstracts/men-s-health/erectile-dysfunction/126306-low-intensity-shockwave-therapy-in-combination-with-phosphodiesterase-5-inhibitors-is-an-effective-and-safe-treatment-option-in-patients-with-vasculogenic-ed-who-are-pde5i-non-responders-a-multice?pk_campaign=Cai_SocialBTA_126306&fbclid=IwAR1WxKgPZ99p3e3PeXS2n9MkVxb1Mj1bQgSBY8E_Ert8qGEFMYwbn0Gemio

Read more

Timing of radiotherapy after radical prostatectomy

Timing of radiotherapy after radical prostatectomy. Zach Klaassen, MD, MSc Georgia Cancer Center, and Christopher Wallis, MD, PhD Vanderbilt Health discuss the RADICALS-RT trial published in The Lancet Oncology, in this UroToday #JournalClub. #WatchNow 

https://www.urotoday.com/video-lectures/localized-prostate-cancer/video/mediaitem/1950-timing-of-radiotherapy-after-radical-prostatectomy-radicals-rt-journal-club-zachary-klaassen-and-christopher-wallis.html?pk_campaign=KlaassenWallis_SocialVideo_1950&fbclid=IwAR33zKsXS0epuPugtVm_qfEKmuFEcdfPWJB7iEDOjhqTbQnCw-ZN5iOswOM

Read more